An observational study in Osteoporosis, sponsored by Pontifical Catholic University of Argentina. Completed at 1 site in Argentina. Open to female participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2024-04-08.
Sponsored by Pontifical Catholic University of Argentina · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Osteoporosis with a site in Argentina — 1 open to participants now, 2 under way, none of them phase 3. Osteoporosis · Argentina.
Among the 22 studies in Osteoporosis with a site in Argentina, this one is the only one that started in 2013, is one of 3 observational ones, and was the 20th registered.
1,602 studies on the registry are indexed under Osteoporosis; 210 are open to participants now.
Browse Osteoporosis studies →1 of the 22 studies in Osteoporosis with a site in Argentina is open now. Recruiting first, the newest first:
AO Foundation, AO Spine · Sites in Argentina, United States, Brazil and 11 more countries
Ages 50+
A study can be open while its sites in Argentina have not opened yet or have stopped. Only those recruiting at a site in Argentina →
Of the 133 Osteoporosis studies recruiting now, 77 (58%) set no upper age limit and 20 (15%) stop at 75 or younger; 9 take children under 18; 36 take healthy volunteers.
This study: 21 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 1 started in 2013.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 425 is above the median of 160 across 456 observational studies indexed under Osteoporosis.
Median enrollment 1,199 across the 19 interventional studies, 425 across the 3 observational. Of the 20 that completed or were terminated, 12 (60%) have results posted.
This tab as a report to print or save as PDF → With an account.
19 of 22 have an industry lead sponsor. The 10 most frequent:
Pontifical Catholic University of Argentina is the lead sponsor of 3 studies on the registry; none are open to participants now.
Pontifical Catholic University of Argentina has 1 study filed under Osteoporosis — fewer than ten, so there is no comparison to draw.
1 of the studies in Osteoporosis with a site in Argentina that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06577935Angitia BiopharmaceuticalsA Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS) | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 22 studies in Osteoporosis with a site in Argentina, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Ibandronate is a third-generation biphosphonate with recognized antiresorptive efficacy by several international, randomized, double-blind, controlled trials. These studies have not included patients from central america, to the best of our knowledge. Therefore, this open-label, uncontrolled study, was set out to assess the clinical effects of a 6-m treatment course with Ibandronate plus vitamine D and Calcium on bone mineral density and health-related quality of life.
Postmenopausal women with a diagnosis of osteoporosis o with a high risk of developing it in the near future.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Ibandronate 150 mg per month + Vitamine D 400-800 IU and Calcium 500-1000 mg per day
Drug: antiresorptive therapy
Bone Mineral Density
Time frame: 6 months
Health-Related Quality of Life
Time frame: 6 months
Adverse Events
Time frame: 6 months
The record gives a start of Jan 2013, a primary completion of Jun 2015 and a completion of Jun 2015. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pontifical Catholic University of Argentina